U.S. Basic Materials Stock News

Celcuity Inc. recently reported fourth-quarter 2025 results showing a net loss of US$50.97 million, with basic loss per share from continuing operations of US$0.97, and a full-year 2025 net loss of US$177.04 million, or US$3.79 per share, both higher than the prior year. The sharp year-on-year increase in reported net loss highlights the cost of Celcuity’s ongoing development and commercialization efforts as it remains a pre-revenue, clinical-stage biotechnology company. With losses widening...

Casella Waste Systems stock moves after recent share performance Casella Waste Systems (CWST) has caught investor attention after a mixed recent run, with the stock up around 10% over the past week but showing declines over the month and past 3 months. See our latest analysis for Casella Waste Systems. At a share price of $86.23, Casella’s recent 10% 7 day share price return contrasts with weaker 1 month and year to date share price returns. The 1 year total shareholder return of 17.11% and 5...

Investors may be wondering whether Sanmina's share price still reflects good value after its run in recent years, or if most of the opportunity is already priced in. The stock last closed at US$129.29, with returns of 4.2% over 7 days and 5.1% over 30 days. Year to date performance sits at an 18.8% decline, compared with an 83.1% return over 1 year and 127.6% over 3 years. Recent attention on Sanmina has focused on how the business is positioned within the broader technology sector, as...

Citigroup’s downgrade of Bio-Rad Laboratories (BIO) from Buy to Neutral, along with a sharp cut to its price target, has put fresh attention on how investors assess the stock after recent share price moves. See our latest analysis for Bio-Rad Laboratories. At a share price of US$278.85, Bio-Rad’s 1-day share price return of a 0.41% decline sits against a 7-day gain of 3.14% and a 90-day share price return of a 14.33% decline. The 1-year total shareholder return of 21.56% contrasts sharply...

Fidelity National Financial (FNF) is back in focus after several AI driven models downgraded the stock, citing weakening cash flows, recent GAAP net losses, and bearish technical indicators that have raised questions around dividend durability. See our latest analysis for Fidelity National Financial. Recent AI driven downgrades and concerns around cash flows help explain why the 30 day share price return sits at a 6.99% decline and the year to date share price return is down 14.19%, even...

Rhythm Pharmaceuticals recently received a positive opinion from the European Medicines Agency’s CHMP to expand IMCIVREE’s authorization to acquired hypothalamic obesity, and appointed veteran life sciences leader Kim Popovits to its Board, succeeding Ed Mathers. This combination of potential European label expansion for IMCIVREE and added commercialization expertise on the Board may meaningfully influence how Rhythm executes its rare neuroendocrine disease focus. Next, we’ll examine how the...

What recent performance says about Goosehead Insurance (GSHD) With no single headline event driving attention, Goosehead Insurance (GSHD) is drawing interest as investors reassess its share price after recent volatility and a mixed pattern of near term and longer term returns. The stock closed at US$44.49, with a 4.8% gain over the past day and 5.2% over the past week. However, it has recorded an 11.3% decline over the past month, a 39% decline over the past 3 months, and a 36.6% slide year...

Horace Mann Educators (HMN) is back on investors’ radar after fourth quarter 2025 earnings and revenue came in above analyst expectations, prompting fresh interest in how the insurer’s educator focused franchise is being valued. See our latest analysis for Horace Mann Educators. At a share price of US$43.60, Horace Mann Educators has seen modest recent share price strength around its Q4 2025 earnings beat. Its 90 day share price return of 3.82% and five year total shareholder return of 23.67%...

Industrial connectivity launch puts MaxLinear’s new RS-485/RS-422 chips in focus MaxLinear (MXL) has expanded its industrial connectivity portfolio with the MxL8323x RS-485 and RS-422 transceivers, targeting factory automation, motor drives, building security, and other electrically harsh industrial settings. For investors, this product family highlights how MaxLinear is positioning its mixed signal expertise in industrial control systems, a segment that often values long product lifecycles,...

Nu Holdings (NU) is drawing attention after appointing former Amazon executive Diego Piacentini to its board, as the digital bank pursues U.S. banking approval and continues reporting customer and earnings growth. See our latest analysis for Nu Holdings. Nu Holdings’ recent board appointment and push toward U.S. banking approval come as the stock trades at $14.26, with a 5.55% 7 day share price return, a 20.16% 90 day share price decline, and a 46.71% 1 year total shareholder return. This...

Some AnaptysBio, Inc. ( NASDAQ:ANAB ) shareholders may be a little concerned to see that the Independent Director, John...

Check Point Software Technologies Ltd. ( NASDAQ:CHKP ) just reported some strong earnings, and the market reacted...

If you are wondering whether Louisiana-Pacific at around US$72 a share is offering good value or is already pricing in a lot of expectations, this article will help you frame that question using several valuation lenses. The stock has been choppy recently, with a 2.6% gain over the last 7 days, a 7.2% decline over 30 days, and year-to-date returns showing an 11.7% decline, while the 3-year and 5-year returns sit at 35.5% and 22.4% respectively. Recent attention on Louisiana-Pacific has...

JFrog (FROG) is back in focus after upbeat analyst commentary around demand for its software supply chain platform coincided with a new integration into Cursor’s AI coding agent, tying the stock more tightly to AI development workflows. See our latest analysis for JFrog. That Cursor plugin launch and recent analyst upgrades have come after a choppy period, with a 21.48% 30 day share price return and a 17.22% year to date share price decline sitting alongside a 73.08% 1 year total shareholder...

Why First Industrial Realty Trust is on investors’ radar First Industrial Realty Trust (FR) has drawn attention after recent trading left the shares around $58.45, with the real estate investment trust showing a mix of short term pullbacks and longer term gains. See our latest analysis for First Industrial Realty Trust. Recent trading has been choppy, with a 2.08% 7 day share price return and a 2.34% 1 month share price decline, while the 1 year total shareholder return of 33.58% points to...

Western Midstream Partners: Recent Returns and Business Context Western Midstream Partners (WES) has drawn investor attention after a mix of short term share price declines alongside stronger longer term total returns, prompting closer scrutiny of how its current performance lines up with its midstream energy operations. See our latest analysis for Western Midstream Partners. Recent trading has been softer, with a 1-day share price return decline of 0.70% and a 30-day share price return...

In the past few days, Trinity Capital Inc. reported fourth-quarter 2025 earnings of US$0.52 per share on US$83.24 million in revenue, committed US$50 million in growth capital to London-based proptech firm Dwelly, and saw director Ronald E. Estes purchase 200 company shares. Together, the earnings beat, sizeable Dwelly funding commitment, and insider share purchase highlight how Trinity Capital is deploying capital while signaling confidence in its lending and investment model. Next, we'll...

In March 2026, DoubleVerify announced that Spectrum Reach became the first partner in its Certified Transparent Streaming program, agreeing to share show-level, privacy-safe data across news, live sports and other streaming TV inventory directly into DV’s Authentic Streaming TV reporting. This move gives advertisers granular, verified insights into the specific programs their streaming ads appear alongside, potentially deepening trust in DoubleVerify’s measurement platform and strengthening...

Q3 2025 earnings beat sparks fresh interest in Globant Globant (GLOB) is back on investor radars after Q3 2025 results came in slightly ahead of guidance, highlighting steady demand for its higher value digital transformation and AI focused services despite currency headwinds. See our latest analysis for Globant. Despite the earnings beat, Globant’s share price has had a tough year, with a 90 day share price return of 33.45% and a 1 year total shareholder return of 54.55% pointing to fading...

Installed Building Products recently reported fourth-quarter earnings per share of US$3.24, beating expectations while revealing a 9% sales decline in its residential segment and announcing a new US$500 million share repurchase program alongside higher dividends. Management also reduced near-term revenue guidance and cited severe winter weather as a key factor pressuring residential insulation demand, even as commercial activity and acquisition efforts provided a partial offset. Next, we’ll...

Chewy, Inc. has reported its fourth-quarter and full-year 2025 results, with quarterly sales of US$3,264.7 million and net income of US$39.2 million, alongside a completed share repurchase of 7,893,480 shares for US$250.95 million under its May 2024 buyback program. While annual sales grew to US$12,601.5 million, full-year net income fell to US$222.8 million, highlighting that margin pressure persisted even as the company returned capital through buybacks and saw earnings per share decrease...

In late March 2026, BioNTech SE paused a COVID-19 vaccine trial with Pfizer due to weak enrollment while also presenting updated lung cancer data at the European Lung Cancer Congress and World Vaccine Congress, highlighting progress across pumitamig, gotistobart, and HER3-targeted ADC candidate BNT326/YL202. The combination of a halted infectious disease study and encouraging lung cancer results underlines BioNTech’s ongoing shift from pandemic vaccines toward a broader oncology-focused...

If you are wondering whether QuidelOrtho's current share price reflects its underlying value, this article walks through the key numbers that investors tend to focus on before making a decision. QuidelOrtho last closed at US$15.88, with returns of 4.1% over the past week, a 23.8% decline over the past month, and year to date and 1 year returns of 44.8% and 44.0% declines respectively. The 3 year and 5 year returns sit at 82.5% and 87.5% declines. These moves come as investors reassess the...

Enterprise Products Partners recently presented at the World Chemical Forum 2026, while also reporting quarterly revenue and earnings that surpassed analyst expectations and prompted positive estimate revisions. What stands out is that analysts now see the partnership’s earnings outlook improving even as it continues to trade at a discount to peers, highlighting a perceived gap between fundamentals and valuation. With this strong earnings surprise and upgraded forecasts in mind, we’ll now...